Nanopath, a women's health diagnostics startup, recently closed a $10 million in Series A funding round. The company will use the money to develop and commercialize its platform, which aims to diagnose women's pelvic and gynecologic infections within minutes.
Molecular testing labs are becoming much more prominent and one reason for their rise is an increased emphasis on evidence-based precision medicine.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
While many of us have avoided exposure to Covid-19 by sheltering in place, patients with advanced cancer have faced difficult choices about moving ahead with immune-compromising, but potentially life-saving treatments, and leaving the safety of their homes to receive infusions at hospitals or treatment centers. Even more challenging, for many patients, the pandemic has altered […]
The ability to more accurately define the different types of cancer, it could lead to lowering costs for treatment and reducing complications.
The molecular diagnostic company has brought in a new round of funding primarily dedicated toward securing regulatory clearance for the company's oncology diagnostic program TR(ACE) assay.
More than 25 million people in the U.S. have asthma, but diagnosing it and figuring out what triggers it can be challenging, especially in young children. An “electronic nose” device being tested by a team at Academic Medical Centre in Amsterdam aims to make the one-size-fits-all approach to asthma treatment a thing of the past. […]
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.